Current Protein Identity:Q9UKK3 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
11JF RNA Vault bound to PARP4 MINT, focused refinement (MVP/PARP4/TEP1 NADP sample) Deposited 2026-02-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain P 1–1724(1724 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 Tris 8.0, 75 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 1 mM NADP, 0.025% DDM
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.85 Å
8SWY PARP4 ART domain bound to NADH Deposited 2023-05-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 242–282(41 aa)
Chain A 365–573(209 aa)
Not recorded NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;21% PEG3350, 0.2M sodium citrate tribasic dihydrate, 1% ethylene glycol, 800uM NADH
Resolution 2.55 Å R-free 0.254
8SWY PARP4 ART domain bound to NADH Deposited 2023-05-19 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 242–282(41 aa)
Chain B 365–573(209 aa)
Not recorded NAI 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE × 1 GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;21% PEG3350, 0.2M sodium citrate tribasic dihydrate, 1% ethylene glycol, 800uM NADH
Resolution 2.55 Å R-free 0.254
8SWY PARP4 ART domain bound to NADH Deposited 2023-05-19 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 242–282(41 aa)
Chain C 365–573(209 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;21% PEG3350, 0.2M sodium citrate tribasic dihydrate, 1% ethylene glycol, 800uM NADH
Resolution 2.55 Å R-free 0.254
8SWZ PARP4 ART domain bound to EB47 Deposited 2023-05-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 242–282(41 aa)
Chain A 365–573(209 aa)
Not recorded GOL GLYCEROL × 1 UHB 2-[4-[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]carbonylpiperazin-1-yl]-N-(1-oxidanylidene-2,3-dihydroisoindol-4-yl)ethanamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG3350, 0.2M sodium citrate tribasic dihydrate, 800uM EB47
Resolution 3.00 Å R-free 0.248
8SWZ PARP4 ART domain bound to EB47 Deposited 2023-05-19 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 242–282(41 aa)
Chain B 365–573(209 aa)
Not recorded GOL GLYCEROL × 1 UHB 2-[4-[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]carbonylpiperazin-1-yl]-N-(1-oxidanylidene-2,3-dihydroisoindol-4-yl)ethanamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG3350, 0.2M sodium citrate tribasic dihydrate, 800uM EB47
Resolution 3.00 Å R-free 0.248
8SWZ PARP4 ART domain bound to EB47 Deposited 2023-05-19 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 242–282(41 aa)
Chain C 365–573(209 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;20% PEG3350, 0.2M sodium citrate tribasic dihydrate, 800uM EB47
Resolution 3.00 Å R-free 0.248
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain D 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 5 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain E 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 6 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain F 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 7 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain G 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX1 PARP4 catalytic domain Deposited 2023-05-19 Assembly 8 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain H 242–573(332 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350 and 0.1 M Bis-Tris pH 6.5
Resolution 4.20 Å R-free 0.331
8SX2 PARP4 catalytic domain bound to EB47 Deposited 2023-05-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 242–573(332 aa)
Not recorded UHB 2-[4-[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]carbonylpiperazin-1-yl]-N-(1-oxidanylidene-2,3-dihydroisoindol-4-yl)ethanamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350, 0.1 M Bis-Tris pH 6.5, 0.2 M MgCl2, and 600 uM EB47
Resolution 2.95 Å R-free 0.262
8SX2 PARP4 catalytic domain bound to EB47 Deposited 2023-05-19 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 242–573(332 aa)
Not recorded UHB 2-[4-[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]carbonylpiperazin-1-yl]-N-(1-oxidanylidene-2,3-dihydroisoindol-4-yl)ethanamide × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;23% PEG3350, 0.1 M Bis-Tris pH 6.5, 0.2 M MgCl2, and 600 uM EB47
Resolution 2.95 Å R-free 0.262
9BW6 Human Vault Cage in complex with PARP4 Deposited 2024-05-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 156 PDB declaration: 156-meric(156) Consistent with protein count
Chain B 1–1724(1724 aa)
Chain D 1–1724(1724 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions Cryogen ETHANE;Vitrification carried out under standard conditions
Resolution 2.90 Å
9BW6 Human Vault Cage in complex with PARP4 Deposited 2024-05-20 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–1724(1724 aa)
Chain D 1–1724(1724 aa)
Not recorded No recorded non-water small molecule ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions Cryogen ETHANE;Vitrification carried out under standard conditions
Resolution 2.90 Å
9BW7 Human Vault Cage in complex with PARP4 and NAD+ Deposited 2024-05-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 156 PDB declaration: 156-meric(156) Consistent with protein count
Chain B 1–1724(1724 aa)
Chain D 1–1724(1724 aa)
Not recorded NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 78 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions Cryogen ETHANE;Vitrification carried out under standard conditions
Resolution 2.90 Å
9BW7 Human Vault Cage in complex with PARP4 and NAD+ Deposited 2024-05-20 Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1–1724(1724 aa)
Chain D 1–1724(1724 aa)
Not recorded NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE × 2 ELECTRON MICROSCOPY
cryo-EM buffer pH 8;50 mM HEPES, 5 mM MgCl2, 5 mM CaCl2, 0.25 mM DTT
cryo-EM vitrification conditions Cryogen ETHANE;Vitrification carried out under standard conditions
Resolution 2.90 Å
9DEV PARP4 BRCT domain Deposited 2024-08-29 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–100(100 aa)
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;2M ammonium sulfate, 0.15M Citric Acid pH3.5
Resolution 1.75 Å R-free 0.188
9DFO PARP4 BRCT domain K31Q mutant Deposited 2024-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–100(100 aa)
Mutation:K31Q SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;31% PEG3350, 0.2M ammonium sulfate and 0.1M sodium acetate pH 4.6
Resolution 1.90 Å R-free 0.208
9DFP PARP4 BRCT domain K23/24Q mutant Deposited 2024-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–100(100 aa)
Mutation:K23Q,K24Q SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;27% PEG3350, 0.2M ammonium sulfate and 0.1M sodium acetate pH 4.6
Resolution 1.92 Å R-free 0.219
9DFQ PARP4 BRCT domain F39Q mutant Deposited 2024-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–100(100 aa)
Mutation:F39Q SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;2 M ammonium sulfate and 0.1 M sodium acetate pH 4.6
Resolution 2.10 Å R-free 0.230
9DFR PARP4 BRCT domain F39A mutant Deposited 2024-08-30 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–100(100 aa)
Mutation:F39A SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;27% PEG3350, 0.2M ammonium sulfate and 0.1M sodium acetate pH 4.6
Resolution 1.90 Å R-free 0.218